European Union regulatory workshop on medication errors

• Date:
  Ceturtdiena, 28 Februāris 2013, Visu dienu
• Vieta:
  European Medicines Agency, Amsterdam, the Netherlands

The workshop is organised by the European Union regulatory network and is aimed at raising awareness of this important public-health issue, discussing the new legal requirements for reporting medication errors and developing best practice among stakeholders. Preregistration open until 21/12/2012. Registration closed.

Documents

Medication-errors workshop report

Reference Number: EMA/144458/2013

Medication-errors workshop - List of participants

Reference Number: EMA/109271/2013

Agenda - Medication-errors workshop - Final programme

Reference Number: EMA/35980/2013

Medication-errors workshop - Call for expressions of interest

Draft Reference Number: EMA/637233/2012

Presentation - Introduction and objectives of the medication-errors workshop (Peter Arlett)

Presentation - Public-health burden of medication errors and how this might be addressed through the European Union pharmacovigilance system (David Cousins)

Presentation - Do we have a common understanding of medication errors? (Jeffrey Aronson, Robin Ferner)

Presentation - CHMP position paper on medication errors in the context of benefit/risk (Andrea Laslop)

Presentation - Evaluation, classification and weighting of medication errors from an industry perspective (Liz Swain)

Presentation - Medication errors in children (Ian Chi Kei Wong)

Presentation - Medication errors: older patients and their caregivers (Denis O’Mahony)

Presentation - Reporting medication errors at national level: what should be reported and to whom (Mick Foy)

Presentation - Reporting experience from national patient-safety organisations (Maria Jose Otero)

Presentation - Guidance to patients and consumers on medication-error reporting (Kaisa Immonen-Charalambous)

Presentation - Discussion of legal consequences of reporting for healthcare professionals (Carlos Maria Romeo-Casabona)

Presentation - Operational definition of medication error for European Union reporting requirements (Thomas Goedecke)

Presentation - Good practice: Medical Dictionary for Regulatory Activities coding of case reports resulting in harm (Sabine Brosch)

Presentation - Spontaneous reporting: detecting medication errors and suitability of current systems (Phil Tregunno)

Presentation - Identification of preventable adverse drug reactions from a regulatory perspective (Almath Spooner)

Presentation - Root-cause analysis in context of World Health Organization international classification for patient safety (David Cousins)

Presentation - Medication names and medication errors (Annemarie Hellebek)

Presentation - A re-design evaluation from the real world (Annemarie Hellebek)

Presentation - Regulatory tools for managing the risk of medication errors: labelling and patient information (Jan MacDonald)

Presentation - Minimising harm through education (Tony West)

Presentation - Medication errors: development of prevention strategies for medicines and medical devices (Laurent Auclert)

Presentation - Regulatory tools for risk minimisation and their effectiveness: monitoring health outcomes and patient compliance (Sabine Straus)

Presentation - Best-practice communication for healthcare professionals and patients (Angeles Alonso-Garcia)

Presentation - Implementation report on the patient safety recommendation 2009/C151/01 (Directorate General for Health and Consumers)

Presentation - Adverse reactions from medication errors: regulatory experience in European Union (Dolores Montero)

Presentation - Medication errors: what patients can do to minimise them (Francois Houyez)

Presentation - Medication errors: FDA perspective (Carol Holquist)

Presentation - Medication-errors workshop: Closing remarks (Peter Arlett)

Multimedia